USA Insulin Delivery Systems Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.

    An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monit oring and carbohydrate counting.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Insulin Delivery Systems market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Insulin Delivery Systems market. Detailed analysis of key players, along with key growth strategies adopted by Insulin Delivery Systems industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Ypsomed Holding

    • Biocon

    • Insulet Corporation

    • Tandem Diabetes Care

    • Becton, Dickinson and Company

    • Medtronic

    • Novo Nordisk

    • Animas Corporation

    • Sanofi

    • ELI Lilly and Company

    By Type:

    • Pens

    • Pumps

    • Pen Needles

    • Syringes

    By End-User:

    • Patients/Homecare

    • Hospitals & Clinics

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Insulin Delivery Systems Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Insulin Delivery Systems Market Size and Growth Rate of Pens from 2016 to 2027

      • 1.3.2 USA Insulin Delivery Systems Market Size and Growth Rate of Pumps from 2016 to 2027

      • 1.3.3 USA Insulin Delivery Systems Market Size and Growth Rate of Pen Needles from 2016 to 2027

      • 1.3.4 USA Insulin Delivery Systems Market Size and Growth Rate of Syringes from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Insulin Delivery Systems Market Size and Growth Rate of Patients/Homecare from 2016 to 2027

      • 1.4.2 USA Insulin Delivery Systems Market Size and Growth Rate of Hospitals & Clinics from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Insulin Delivery Systems Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Insulin Delivery Systems by Major Types

      • 3.4.1 Market Size and Growth Rate of Pens

      • 3.4.2 Market Size and Growth Rate of Pumps

      • 3.4.3 Market Size and Growth Rate of Pen Needles

      • 3.4.4 Market Size and Growth Rate of Syringes

    4 Segmentation of Insulin Delivery Systems Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Insulin Delivery Systems by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Insulin Delivery Systems in Patients/Homecare

      • 4.4.2 Market Size and Growth Rate of Insulin Delivery Systems in Hospitals & Clinics

    5 Market Analysis by Regions

    • 5.1 USA Insulin Delivery Systems Production Analysis by Regions

    • 5.2 USA Insulin Delivery Systems Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Insulin Delivery Systems Landscape Analysis

    • 6.1 West USA Insulin Delivery Systems Landscape Analysis by Major Types

    • 6.2 West USA Insulin Delivery Systems Landscape Analysis by Major End-Users

    7 South USA Insulin Delivery Systems Landscape Analysis

    • 7.1 South USA Insulin Delivery Systems Landscape Analysis by Major Types

    • 7.2 South USA Insulin Delivery Systems Landscape Analysis by Major End-Users

    8 Middle West USA Insulin Delivery Systems Landscape Analysis

    • 8.1 Middle West USA Insulin Delivery Systems Landscape Analysis by Major Types

    • 8.2 Middle West USA Insulin Delivery Systems Landscape Analysis by Major End-Users

    9 Northeast USA Insulin Delivery Systems Landscape Analysis

    • 9.1 Northeast USA Insulin Delivery Systems Landscape Analysis by Major Types

    • 9.2 Northeast USA Insulin Delivery Systems Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Ypsomed Holding

        • 10.1.1 Ypsomed Holding Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Biocon

        • 10.2.1 Biocon Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Insulet Corporation

        • 10.3.1 Insulet Corporation Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Tandem Diabetes Care

        • 10.4.1 Tandem Diabetes Care Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Becton, Dickinson and Company

        • 10.5.1 Becton, Dickinson and Company Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Medtronic

        • 10.6.1 Medtronic Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Novo Nordisk

        • 10.7.1 Novo Nordisk Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Animas Corporation

        • 10.8.1 Animas Corporation Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Sanofi

        • 10.9.1 Sanofi Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 ELI Lilly and Company

        • 10.10.1 ELI Lilly and Company Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Insulin Delivery Systems Market Size and Growth Rate of Pens from 2016 to 2027

    • Figure USA Insulin Delivery Systems Market Size and Growth Rate of Pumps from 2016 to 2027

    • Figure USA Insulin Delivery Systems Market Size and Growth Rate of Pen Needles from 2016 to 2027

    • Figure USA Insulin Delivery Systems Market Size and Growth Rate of Syringes from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Insulin Delivery Systems Market Size and Growth Rate of Patients/Homecare from 2016 to 2027

    • Figure USA Insulin Delivery Systems Market Size and Growth Rate of Hospitals & Clinics from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Insulin Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Insulin Delivery Systems Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Insulin Delivery Systems

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Insulin Delivery Systems by Different Types from 2016 to 2027

    • Table Consumption Share of Insulin Delivery Systems by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Pens

    • Figure Market Size and Growth Rate of Pumps

    • Figure Market Size and Growth Rate of Pen Needles

    • Figure Market Size and Growth Rate of Syringes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Insulin Delivery Systems by Different End-Users from 2016 to 2027

    • Table Consumption Share of Insulin Delivery Systems by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Patients/Homecare

    • Figure Market Size and Growth Rate of Hospitals & Clinics

    • Table USA Insulin Delivery Systems Production by Regions

    • Table USA Insulin Delivery Systems Production Share by Regions

    • Figure USA Insulin Delivery Systems Production Share by Regions in 2016

    • Figure USA Insulin Delivery Systems Production Share by Regions in 2021

    • Figure USA Insulin Delivery Systems Production Share by Regions in 2027

    • Table USA Insulin Delivery Systems Consumption by Regions

    • Table USA Insulin Delivery Systems Consumption Share by Regions

    • Figure USA Insulin Delivery Systems Consumption Share by Regions in 2016

    • Figure USA Insulin Delivery Systems Consumption Share by Regions in 2021

    • Figure USA Insulin Delivery Systems Consumption Share by Regions in 2027

    • Table West USA Insulin Delivery Systems Consumption by Types from 2016 to 2027

    • Table West USA Insulin Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure West USA Insulin Delivery Systems Consumption Share by Types in 2016

    • Figure West USA Insulin Delivery Systems Consumption Share by Types in 2021

    • Figure West USA Insulin Delivery Systems Consumption Share by Types in 2027

    • Table West USA Insulin Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table West USA Insulin Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Insulin Delivery Systems Consumption Share by End-Users in 2016

    • Figure West USA Insulin Delivery Systems Consumption Share by End-Users in 2021

    • Figure West USA Insulin Delivery Systems Consumption Share by End-Users in 2027

    • Table South USA Insulin Delivery Systems Consumption by Types from 2016 to 2027

    • Table South USA Insulin Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure South USA Insulin Delivery Systems Consumption Share by Types in 2016

    • Figure South USA Insulin Delivery Systems Consumption Share by Types in 2021

    • Figure South USA Insulin Delivery Systems Consumption Share by Types in 2027

    • Table South USA Insulin Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table South USA Insulin Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Insulin Delivery Systems Consumption Share by End-Users in 2016

    • Figure South USA Insulin Delivery Systems Consumption Share by End-Users in 2021

    • Figure South USA Insulin Delivery Systems Consumption Share by End-Users in 2027

    • Table Middle West USA Insulin Delivery Systems Consumption by Types from 2016 to 2027

    • Table Middle West USA Insulin Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Insulin Delivery Systems Consumption Share by Types in 2016

    • Figure Middle West USA Insulin Delivery Systems Consumption Share by Types in 2021

    • Figure Middle West USA Insulin Delivery Systems Consumption Share by Types in 2027

    • Table Middle West USA Insulin Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Insulin Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Insulin Delivery Systems Consumption Share by End-Users in 2016

    • Figure Middle West USA Insulin Delivery Systems Consumption Share by End-Users in 2021

    • Figure Middle West USA Insulin Delivery Systems Consumption Share by End-Users in 2027

    • Table Northeast USA Insulin Delivery Systems Consumption by Types from 2016 to 2027

    • Table Northeast USA Insulin Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Insulin Delivery Systems Consumption Share by Types in 2016

    • Figure Northeast USA Insulin Delivery Systems Consumption Share by Types in 2021

    • Figure Northeast USA Insulin Delivery Systems Consumption Share by Types in 2027

    • Table Northeast USA Insulin Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Insulin Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Insulin Delivery Systems Consumption Share by End-Users in 2016

    • Figure Northeast USA Insulin Delivery Systems Consumption Share by End-Users in 2021

    • Figure Northeast USA Insulin Delivery Systems Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Ypsomed Holding

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ypsomed Holding

    • Figure Sales and Growth Rate Analysis of Ypsomed Holding

    • Figure Revenue and Market Share Analysis of Ypsomed Holding

    • Table Product and Service Introduction of Ypsomed Holding

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Insulet Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Insulet Corporation

    • Figure Sales and Growth Rate Analysis of Insulet Corporation

    • Figure Revenue and Market Share Analysis of Insulet Corporation

    • Table Product and Service Introduction of Insulet Corporation

    • Table Company Profile and Development Status of Tandem Diabetes Care

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tandem Diabetes Care

    • Figure Sales and Growth Rate Analysis of Tandem Diabetes Care

    • Figure Revenue and Market Share Analysis of Tandem Diabetes Care

    • Table Product and Service Introduction of Tandem Diabetes Care

    • Table Company Profile and Development Status of Becton, Dickinson and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton, Dickinson and Company

    • Figure Sales and Growth Rate Analysis of Becton, Dickinson and Company

    • Figure Revenue and Market Share Analysis of Becton, Dickinson and Company

    • Table Product and Service Introduction of Becton, Dickinson and Company

    • Table Company Profile and Development Status of Medtronic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic

    • Figure Sales and Growth Rate Analysis of Medtronic

    • Figure Revenue and Market Share Analysis of Medtronic

    • Table Product and Service Introduction of Medtronic

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Animas Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Animas Corporation

    • Figure Sales and Growth Rate Analysis of Animas Corporation

    • Figure Revenue and Market Share Analysis of Animas Corporation

    • Table Product and Service Introduction of Animas Corporation

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of ELI Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ELI Lilly and Company

    • Figure Sales and Growth Rate Analysis of ELI Lilly and Company

    • Figure Revenue and Market Share Analysis of ELI Lilly and Company

    • Table Product and Service Introduction of ELI Lilly and Company


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.